BioNTech SE is 1.2x more valuable than Moderna, Inc. by market capitalization ($22.18 B vs $18.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BNTX | MRNA |
|---|---|---|
| Market cap | $22.18 B | $18.86 B |
| US-listed rank | #582 | #643 |
| Revenue (latest FY) | - | $1.94B |
| Net income (latest FY) | - | -$2.82B |
| Net margin | - | -145.2% |
| SEC filings | 548 | 1,447 |
BioNTech SE is 1.2x more valuable than Moderna, Inc. by market capitalization ($22.18 B vs $18.86 B).
Full pages: BioNTech SE and Moderna, Inc., or browse the full rankings.